AbCellera Biologics Inc. develops an antibody discovery platform. The company is headquartered in Vancouver, Canada. Show more

150 W 4TH AVENUE, VANCOUVER, BC, CANADA, V5Y 1G6, Vancouver, BC, V5Y 1G6, USA

BIOTECHNOLOGY

HEALTHCARE

Market Cap

3.704B

52 Wk Range

$2.75 - $12.58

Previous Close

$11.57

Open

$11.50

Volume

2,019,253

Day Range

$11.33 - $11.59

Enterprise Value

3.345B

Cash

120.1M

Avg Qtr Burn

-33.86M

Insider Ownership

21.74%

Institutional Own.

36.68%

Qtr Updated

06/30/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Bebtelovimab (LY-CoV1404) Details COVID-19	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Bamlanivimab (LY-CoV555) Details COVID-19	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABCL635 Details Moderate-to-severe vasomotor symptoms (VMS) or "hot flashes"	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABCL575 Details Moderate-to-severe atopic dermatitis (AD)	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.